Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Zhejiang Taimei Medical Technology Co Ltd Class H ( (HK:2576) ) just unveiled an update.
Zhejiang Taimei Medical Technology Co., Ltd. reported a decrease in revenue and gross profit for the first half of 2025 compared to the same period in 2024, with revenue dropping by 10.5% and gross profit by 9.7%. Despite the decline in revenue, the company significantly reduced its operating loss by 74.6% and its loss for the period by 83.3%, indicating improved operational efficiency and cost management.
The most recent analyst rating on (HK:2576) stock is a Hold with a HK$5.00 price target. To see the full list of analyst forecasts on Zhejiang Taimei Medical Technology Co Ltd Class H stock, see the HK:2576 Stock Forecast page.
More about Zhejiang Taimei Medical Technology Co Ltd Class H
Zhejiang Taimei Medical Technology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating within the medical technology industry. The company focuses on providing medical technology solutions, although specific products or services are not detailed in the announcement.
Average Trading Volume: 82,865
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$2.88B
Find detailed analytics on 2576 stock on TipRanks’ Stock Analysis page.